nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifapentine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.134	0.135	CbGbCtD
Rifapentine—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.123	0.124	CbGbCtD
Rifapentine—CYP3A7—Progesterone—uterine cancer	0.123	0.124	CbGbCtD
Rifapentine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0934	0.0945	CbGbCtD
Rifapentine—CYP3A5—Progesterone—uterine cancer	0.0923	0.0933	CbGbCtD
Rifapentine—CYP2C8—Progesterone—uterine cancer	0.0887	0.0898	CbGbCtD
Rifapentine—CYP2C9—Progesterone—uterine cancer	0.0619	0.0626	CbGbCtD
Rifapentine—CYP2D6—Progesterone—uterine cancer	0.0566	0.0572	CbGbCtD
Rifapentine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0543	0.0549	CbGbCtD
Rifapentine—CYP3A5—Etoposide—uterine cancer	0.0413	0.0418	CbGbCtD
Rifapentine—CYP2C8—Etoposide—uterine cancer	0.0397	0.0402	CbGbCtD
Rifapentine—CYP3A4—Progesterone—uterine cancer	0.036	0.0364	CbGbCtD
Rifapentine—CYP2D6—Doxorubicin—uterine cancer	0.0173	0.0175	CbGbCtD
Rifapentine—CYP3A4—Etoposide—uterine cancer	0.0161	0.0163	CbGbCtD
Rifapentine—CYP3A4—Doxorubicin—uterine cancer	0.011	0.0111	CbGbCtD
Rifapentine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000395	0.0346	CbGpPWpGaD
Rifapentine—CYP3A43—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00039	0.0341	CbGpPWpGaD
Rifapentine—CYP3A43—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00032	0.028	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—AKR1B10—uterine cancer	0.000302	0.0264	CbGpPWpGaD
Rifapentine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000299	0.0262	CbGpPWpGaD
Rifapentine—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000291	0.0254	CbGpPWpGaD
Rifapentine—CYP3A43—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000287	0.0251	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—AKR1B1—uterine cancer	0.00028	0.0246	CbGpPWpGaD
Rifapentine—CYP3A43—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000236	0.0206	CbGpPWpGaD
Rifapentine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00023	0.0202	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—AKR1C1—uterine cancer	0.000206	0.018	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—GPX3—uterine cancer	0.000181	0.0158	CbGpPWpGaD
Rifapentine—CYP3A43—Biological oxidations—CYP11A1—uterine cancer	0.00017	0.0149	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—CYP11A1—uterine cancer	0.000168	0.0147	CbGpPWpGaD
Rifapentine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000159	0.0139	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—AKR1C3—uterine cancer	0.000158	0.0139	CbGpPWpGaD
Rifapentine—CYP3A7—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000157	0.0137	CbGpPWpGaD
Rifapentine—CYP3A7—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000129	0.0113	CbGpPWpGaD
Rifapentine—CYP3A43—Biological oxidations—CYP19A1—uterine cancer	0.000125	0.011	CbGpPWpGaD
Rifapentine—CYP3A43—Metapathway biotransformation—CYP19A1—uterine cancer	0.000123	0.0108	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—AKR1B10—uterine cancer	0.000121	0.0106	CbGpPWpGaD
Rifapentine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000117	0.0103	CbGpPWpGaD
Rifapentine—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000116	0.0101	CbGpPWpGaD
Rifapentine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000115	0.0101	CbGpPWpGaD
Rifapentine—CYP3A5—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000113	0.00994	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—AKR1B1—uterine cancer	0.000113	0.00989	CbGpPWpGaD
Rifapentine—CYP2C8—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000109	0.00953	CbGpPWpGaD
Rifapentine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	9.96e-05	0.00872	CbGpPWpGaD
Rifapentine—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	9.83e-05	0.00861	CbGpPWpGaD
Rifapentine—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	9.49e-05	0.00831	CbGpPWpGaD
Rifapentine—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9.32e-05	0.00816	CbGpPWpGaD
Rifapentine—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	8.86e-05	0.00776	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—AKR1B10—uterine cancer	8.78e-05	0.00769	CbGpPWpGaD
Rifapentine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.46e-05	0.00741	CbGpPWpGaD
Rifapentine—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.35e-05	0.00731	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—AKR1C1—uterine cancer	8.29e-05	0.00726	CbGpPWpGaD
Rifapentine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.18e-05	0.00716	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—AKR1B1—uterine cancer	8.16e-05	0.00715	CbGpPWpGaD
Rifapentine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.11e-05	0.0071	CbGpPWpGaD
Rifapentine—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.07e-05	0.00707	CbGpPWpGaD
Rifapentine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8.07e-05	0.00707	CbGpPWpGaD
Rifapentine—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8e-05	0.00701	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—AKR1B10—uterine cancer	7.6e-05	0.00666	CbGpPWpGaD
Rifapentine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.33e-05	0.00642	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—GPX3—uterine cancer	7.28e-05	0.00637	CbGpPWpGaD
Rifapentine—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.23e-05	0.00633	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—AKR1B1—uterine cancer	7.07e-05	0.00619	CbGpPWpGaD
Rifapentine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.86e-05	0.00601	CbGpPWpGaD
Rifapentine—CYP3A7—Biological oxidations—CYP11A1—uterine cancer	6.85e-05	0.006	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—CYP11A1—uterine cancer	6.76e-05	0.00592	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—NDUFB11—uterine cancer	6.72e-05	0.00589	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—SRD5A2—uterine cancer	6.72e-05	0.00589	CbGpPWpGaD
Rifapentine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.63e-05	0.00581	CbGpPWpGaD
Rifapentine—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	6.57e-05	0.00576	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—AKR1C3—uterine cancer	6.38e-05	0.00559	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—AKR1B10—uterine cancer	6.24e-05	0.00547	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	6.19e-05	0.00542	CbGpPWpGaD
Rifapentine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.02e-05	0.00527	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	5.99e-05	0.00525	CbGpPWpGaD
Rifapentine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	5.96e-05	0.00522	CbGpPWpGaD
Rifapentine—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.94e-05	0.0052	CbGpPWpGaD
Rifapentine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.94e-05	0.0052	CbGpPWpGaD
Rifapentine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	5.89e-05	0.00515	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	5.8e-05	0.00508	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	5.75e-05	0.00504	CbGpPWpGaD
Rifapentine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	5.35e-05	0.00468	CbGpPWpGaD
Rifapentine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	5.28e-05	0.00462	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	5.26e-05	0.00461	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	5.19e-05	0.00454	CbGpPWpGaD
Rifapentine—CYP3A7—Biological oxidations—CYP19A1—uterine cancer	5.04e-05	0.00441	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—CYP19A1—uterine cancer	4.97e-05	0.00435	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	4.95e-05	0.00434	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	4.88e-05	0.00428	CbGpPWpGaD
Rifapentine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.88e-05	0.00427	CbGpPWpGaD
Rifapentine—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	4.86e-05	0.00426	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—AKR1B1—uterine cancer	4.86e-05	0.00426	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—STAR—uterine cancer	4.86e-05	0.00426	CbGpPWpGaD
Rifapentine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.83e-05	0.00423	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	4.61e-05	0.00404	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	4.56e-05	0.00399	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	4.33e-05	0.0038	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	4.29e-05	0.00376	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	4.26e-05	0.00373	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	4.23e-05	0.0037	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	4.22e-05	0.0037	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.08e-05	0.00357	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	3.99e-05	0.0035	CbGpPWpGaD
Rifapentine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	3.93e-05	0.00344	CbGpPWpGaD
Rifapentine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	3.88e-05	0.0034	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—POLD1—uterine cancer	3.81e-05	0.00334	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.81e-05	0.00333	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	3.79e-05	0.00332	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	3.74e-05	0.00328	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	3.71e-05	0.00325	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	3.64e-05	0.00319	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	3.59e-05	0.00315	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—AKR1C1—uterine cancer	3.57e-05	0.00312	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	3.52e-05	0.00308	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	3.49e-05	0.00306	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	3.47e-05	0.00304	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	3.44e-05	0.00302	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	3.28e-05	0.00287	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	3.25e-05	0.00285	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.19e-05	0.00279	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—RRM2—uterine cancer	3.18e-05	0.00279	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	3.16e-05	0.00276	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	3.11e-05	0.00273	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.1e-05	0.00271	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—DCN—uterine cancer	3.09e-05	0.0027	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CYP11A1—uterine cancer	2.91e-05	0.00255	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	2.79e-05	0.00244	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.75e-05	0.00241	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.75e-05	0.00241	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—AKR1C3—uterine cancer	2.75e-05	0.00241	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—NDUFB11—uterine cancer	2.71e-05	0.00237	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—SRD5A2—uterine cancer	2.71e-05	0.00237	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	2.59e-05	0.00227	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	2.57e-05	0.00225	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	2.56e-05	0.00224	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	2.53e-05	0.00222	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.45e-05	0.00214	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.3e-05	0.00202	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.27e-05	0.00199	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.24e-05	0.00196	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.24e-05	0.00196	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.14e-05	0.00188	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CYP19A1—uterine cancer	2.14e-05	0.00187	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—STK11—uterine cancer	2.14e-05	0.00187	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.02e-05	0.00177	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—STAR—uterine cancer	1.96e-05	0.00171	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—AKR1B1—uterine cancer	1.96e-05	0.00171	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—SRD5A2—uterine cancer	1.96e-05	0.00171	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—NDUFB11—uterine cancer	1.96e-05	0.00171	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—NDUFB11—uterine cancer	1.7e-05	0.00149	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—SRD5A2—uterine cancer	1.7e-05	0.00149	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.69e-05	0.00148	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.67e-05	0.00146	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.65e-05	0.00144	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.64e-05	0.00144	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—MTHFR—uterine cancer	1.61e-05	0.00141	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.56e-05	0.00136	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—POLD1—uterine cancer	1.54e-05	0.00135	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—AKR1C1—uterine cancer	1.44e-05	0.00126	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—STAR—uterine cancer	1.42e-05	0.00124	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—AKR1B1—uterine cancer	1.42e-05	0.00124	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.39e-05	0.00122	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.39e-05	0.00122	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.38e-05	0.00121	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.38e-05	0.00121	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.34e-05	0.00117	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—RRM2—uterine cancer	1.28e-05	0.00112	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.27e-05	0.00111	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—DCN—uterine cancer	1.24e-05	0.00109	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—STAR—uterine cancer	1.23e-05	0.00107	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.23e-05	0.00107	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.21e-05	0.00106	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CYP11A1—uterine cancer	1.17e-05	0.00103	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—POLD1—uterine cancer	1.11e-05	0.000973	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—AKR1C3—uterine cancer	1.11e-05	0.000969	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—AKR1C1—uterine cancer	1.04e-05	0.00091	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—STAR—uterine cancer	1.01e-05	0.000881	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.01e-05	0.000881	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—STAR—uterine cancer	9.98e-06	0.000874	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—AKR1B1—uterine cancer	9.98e-06	0.000874	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.86e-06	0.000864	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—POLD1—uterine cancer	9.62e-06	0.000843	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—RRM2—uterine cancer	9.26e-06	0.000811	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—SRD5A2—uterine cancer	9.1e-06	0.000797	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—NDUFB11—uterine cancer	9.1e-06	0.000797	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—AKR1C1—uterine cancer	9e-06	0.000788	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—DCN—uterine cancer	8.99e-06	0.000787	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PTEN—uterine cancer	8.95e-06	0.000784	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CYP19A1—uterine cancer	8.62e-06	0.000755	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—STK11—uterine cancer	8.62e-06	0.000755	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—EP300—uterine cancer	8.53e-06	0.000747	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CYP11A1—uterine cancer	8.47e-06	0.000742	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—RRM2—uterine cancer	8.02e-06	0.000702	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—AKR1C3—uterine cancer	8e-06	0.0007	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—POLD1—uterine cancer	7.9e-06	0.000692	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—POLD1—uterine cancer	7.83e-06	0.000686	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—DCN—uterine cancer	7.79e-06	0.000682	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—AKR1C1—uterine cancer	7.39e-06	0.000647	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CYP11A1—uterine cancer	7.34e-06	0.000642	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—AKR1C1—uterine cancer	7.32e-06	0.000641	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—AKR1C3—uterine cancer	6.93e-06	0.000607	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—RRM2—uterine cancer	6.58e-06	0.000577	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—AKR1B1—uterine cancer	6.58e-06	0.000576	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—STAR—uterine cancer	6.58e-06	0.000576	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—RRM2—uterine cancer	6.53e-06	0.000572	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—MTHFR—uterine cancer	6.48e-06	0.000567	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—DCN—uterine cancer	6.39e-06	0.00056	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—DCN—uterine cancer	6.34e-06	0.000555	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PIK3CA—uterine cancer	6.31e-06	0.000553	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—STK11—uterine cancer	6.23e-06	0.000546	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CYP19A1—uterine cancer	6.23e-06	0.000546	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CYP11A1—uterine cancer	6.02e-06	0.000527	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CYP11A1—uterine cancer	5.97e-06	0.000523	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—AKR1C3—uterine cancer	5.69e-06	0.000498	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—AKR1C3—uterine cancer	5.64e-06	0.000494	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—STK11—uterine cancer	5.4e-06	0.000473	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CYP19A1—uterine cancer	5.4e-06	0.000473	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—POLD1—uterine cancer	5.16e-06	0.000452	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—AKT1—uterine cancer	5.16e-06	0.000452	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.07e-06	0.000444	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.83e-06	0.000423	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.83e-06	0.000423	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—MTHFR—uterine cancer	4.68e-06	0.00041	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—STK11—uterine cancer	4.43e-06	0.000388	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CYP19A1—uterine cancer	4.43e-06	0.000388	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.39e-06	0.000385	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—STK11—uterine cancer	4.39e-06	0.000385	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—RRM2—uterine cancer	4.3e-06	0.000377	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—DCN—uterine cancer	4.18e-06	0.000366	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.12e-06	0.000361	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—MTHFR—uterine cancer	4.06e-06	0.000355	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.94e-06	0.000345	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.93e-06	0.000344	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.72e-06	0.000326	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PTEN—uterine cancer	3.6e-06	0.000316	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.57e-06	0.000313	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—EP300—uterine cancer	3.44e-06	0.000301	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—MTHFR—uterine cancer	3.33e-06	0.000292	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—MTHFR—uterine cancer	3.3e-06	0.000289	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.91e-06	0.000255	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—STK11—uterine cancer	2.9e-06	0.000254	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.9e-06	0.000254	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PTEN—uterine cancer	2.6e-06	0.000228	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PIK3CA—uterine cancer	2.54e-06	0.000223	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—EP300—uterine cancer	2.48e-06	0.000218	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PTEN—uterine cancer	2.26e-06	0.000198	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—MTHFR—uterine cancer	2.18e-06	0.000191	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—EP300—uterine cancer	2.15e-06	0.000188	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—AKT1—uterine cancer	2.08e-06	0.000182	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PTEN—uterine cancer	1.85e-06	0.000162	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PIK3CA—uterine cancer	1.84e-06	0.000161	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PTEN—uterine cancer	1.84e-06	0.000161	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—EP300—uterine cancer	1.77e-06	0.000155	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—EP300—uterine cancer	1.75e-06	0.000153	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.59e-06	0.000139	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—AKT1—uterine cancer	1.5e-06	0.000131	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.31e-06	0.000114	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—AKT1—uterine cancer	1.3e-06	0.000114	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.3e-06	0.000113	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PTEN—uterine cancer	1.21e-06	0.000106	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—EP300—uterine cancer	1.15e-06	0.000101	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—AKT1—uterine cancer	1.07e-06	9.35e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—AKT1—uterine cancer	1.06e-06	9.27e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PIK3CA—uterine cancer	8.54e-07	7.48e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—AKT1—uterine cancer	6.98e-07	6.11e-05	CbGpPWpGaD
